Ad Code

Record Retention in Pharmaceutical Industry – Complete GMP Guide

GMP DOCUMENTATION • ARCHIVAL • DATA INTEGRITY

Record Retention in the Pharmaceutical Industry

A complete guide to pharmaceutical record retention covering retention policies, retention schedules, batch records, laboratory data, logbooks, training records, validation documents, CAPA, electronic records, archival, retrieval, destruction and ALCOA+ data-integrity requirements.

Record retention is the controlled preservation of pharmaceutical records for a defined period so that evidence of manufacturing, testing, quality decisions and regulatory activities remains available, readable and retrievable when required.

Pharmaceutical companies generate thousands of records through manufacturing, Quality Control, Quality Assurance, engineering, validation, warehousing, training and distribution. These records may later be needed during investigations, product complaints, recalls, regulatory inspections, audits, stability reviews or historical batch evaluations.

Effective retention is therefore an important part of cGMP and the wider pharmaceutical documentation system.

Retain Required GMP Evidence
Protect Against Loss & Damage
Retrieve Records When Needed
Dispose Only When Authorized

What is Record Retention in the Pharmaceutical Industry?

Record retention is the systematic preservation of pharmaceutical records for a predetermined period under conditions that maintain their integrity, readability, accessibility and traceability.

Retention begins after or during the creation of a record and continues until the record reaches its authorized disposition date. During this time, the company should be able to locate and retrieve the record within an appropriate timeframe.

Record retention applies to both paper and electronic records. It also applies to supporting information that is necessary to understand the complete GMP activity.

Why is Record Retention Important in Pharmaceuticals?

Regulatory Compliance

Retention provides documentary evidence that regulated activities were performed according to applicable requirements.

Batch Traceability

Historical records allow individual batches to be reconstructed when necessary.

Investigation Support

Previous manufacturing, laboratory and quality information may help identify the cause of a current problem.

Product Complaints

Historical records may be needed to evaluate complaints after a product has entered the market.

Product Recall

Distribution and batch records help determine the scope of a recall.

Trend Analysis

Historical quality data can support long-term process and product trending.

Inspection Readiness

Archived records may be requested during audits or regulatory inspections.

Knowledge Preservation

Historical documentation preserves important product and process knowledge.

Legal & Business Evidence

Certain retained records may also support contractual, legal or business requirements.

Types of Pharmaceutical Records That Require Retention

1. Batch Manufacturing Records

Executed manufacturing records, processing details, yields, in-process controls and batch signatures.

2. Batch Packaging Records

Packaging activities, component details, coding, reconciliation, line clearance and finished-pack information.

3. Laboratory Records

Analytical worksheets, chromatograms, spectra, calculations, sample records and test results.

4. Stability Records

Stability protocols, test results, chamber records and trend evaluations.

5. Validation Records

Qualification protocols, validation reports, raw data, deviations and approval records.

6. Calibration Records

Calibration results, standards used, acceptance decisions and equipment status.

7. Maintenance Records

Preventive maintenance, repairs, breakdown history and equipment servicing.

8. Training Records

Employee training, competency, qualification and retraining evidence.

9. Deviation & CAPA Records

Investigation records, root-cause analysis, corrective actions and effectiveness checks.

10. Change Control Records

Proposed changes, impact assessments, approvals, implementation and closure documentation.

11. Complaint & Recall Records

Market complaints, investigations, recall decisions and follow-up actions.

12. Logbooks

Equipment, instrument, area, cleaning, calibration, temperature and utility logbooks.

13. Environmental Monitoring Records

Monitoring results, excursions, investigations and associated trend reports.

14. Supplier & Audit Records

Qualification records, supplier assessments, audits and corrective-action responses.

Pharmaceutical Record Retention Policy

A company should establish a written SOP or controlled policy describing how pharmaceutical records are classified, retained, archived, retrieved and destroyed.

Record Classification Define the major categories of paper and electronic records.
Retention Period Define how long each record category must be maintained.
Record Owner Identify which department is responsible for each record type.
Storage Location Define where physical or electronic records will be retained.
Access Control Limit record access to authorized personnel.
Retrieval Define how records can be located and retrieved when requested.
Destruction Define how records are securely destroyed after authorization.
Responsibility Assign responsibility for retention, review, archival and disposal.

How Are Pharmaceutical Record Retention Periods Determined?

There is no single universal retention period that can safely be applied to every pharmaceutical record.

The required period may depend on:

  • Applicable national regulations
  • Market authorization requirements
  • Product type
  • Batch expiry or shelf life
  • Clinical or stability obligations
  • Document type
  • Company quality-system requirements
  • Contractual requirements
  • Ongoing investigations or legal holds

The company should therefore establish a controlled retention schedule that identifies the approved retention basis for each record category.

Example Pharmaceutical Record Retention Matrix

Important: The table below is a template for designing a company retention schedule. It intentionally does not prescribe universal numbers of years. The actual retention period should be entered based on applicable regulatory and company requirements.
Record Type Record Owner Retention Basis Approved Retention Period Storage Location
Batch Manufacturing Record QA / Production Product / GMP regulatory requirement Define in approved schedule Archive / eDMS
Laboratory Raw Data Quality Control Batch / analytical record requirement Define in approved schedule QC archive / validated system
Stability Records Quality Control Stability programme / product requirement Define in approved schedule Archive / LIMS
Validation Records Validation / QA System and equipment lifecycle Define in approved schedule Validation archive
Training Records QA / HR Employment / qualification requirement Define in approved schedule Training system
Deviation / CAPA Quality Assurance Quality-system requirement Define in approved schedule QMS archive
Equipment Logbooks User Department Equipment / batch traceability Define in approved schedule Department / archive
Complaint Records Quality Assurance Product / market requirement Define in approved schedule QMS archive

Pharmaceutical Record Retention Lifecycle

1 Create
2 Review
3 Use
4 Close
5 Archive
6 Retain
7 Dispose

Retention of Paper Pharmaceutical Records

Paper archives should preserve documents in a condition that keeps them readable and retrievable throughout their retention period.

Paper Archive Controls May Include

  • Restricted access
  • Controlled archive location
  • Protection from water and fire
  • Pest-control measures
  • Suitable temperature and humidity where necessary
  • Indexed storage locations
  • Archive-box identification
  • Record check-in and check-out system
  • Protection against unauthorized alteration

Retention of Electronic Pharmaceutical Records

Electronic record retention requires more than simply keeping a computer file. The organization should ensure that regulated records remain accessible, readable and meaningful throughout the required retention period.

Controls may include validated systems, access management, audit trails, metadata preservation, secure storage, backup, disaster recovery, data migration and long-term format readability.

If an old computerized system is replaced, the company should ensure that required historical records remain retrievable and that their context and integrity are preserved.

ALCOA+ and Record Retention

Retention is closely connected with pharmaceutical data integrity. Records should continue to support the principles described in ALCOA+ throughout their lifecycle.

Attributable The record should preserve information about who performed or documented the activity.
Legible Information should remain readable throughout the required retention period.
Contemporaneous Dates and times should accurately reflect when activities occurred.
Original Original data or appropriately managed true copies should be retained where applicable.
Accurate Records should continue to represent the actual activity and results.
Complete Relevant supporting data should not be lost during archival.
Consistent Chronology and record relationships should remain understandable.
Enduring & Available Records should survive throughout retention and remain retrievable when required.

Pharmaceutical Archive Management

Identification Archived records should have clear titles, reference numbers or index information.
Location Control The company should know where each record category is stored.
Security Access should be restricted to authorized personnel.
Environmental Protection Storage conditions should protect records from deterioration.
Retrievability Records should be indexed so they can be located efficiently.
Disaster Protection Important records should be protected through suitable contingency arrangements.

Retrieval of Archived Pharmaceutical Records

Retaining a record has little value if it cannot be found when needed. Archive systems should therefore include an indexing and retrieval process.

Record Retrieval Information May Include

  • Record title
  • Document or batch number
  • Department
  • Archive box or electronic location
  • Retention end date
  • Person requesting the record
  • Date removed from archive
  • Date returned

Difference Between Backup and Record Archival

Feature Backup Archive
Main Purpose Recovery after loss, corruption or system failure. Long-term preservation of required records.
Typical Use System restoration. Inspection, investigation and historical retrieval.
Retention Logic Usually based on technical recovery strategy. Based on regulatory and business retention requirements.
User Retrieval May require system restoration. Should support controlled retrieval of retained records.

A backup strategy should therefore not automatically be treated as a substitute for a defined record-retention and archival strategy.

Destruction of Pharmaceutical Records

Records should not be destroyed merely because storage space is limited. Destruction should occur only after the approved retention period has expired and after any required review or authorization.

Records linked to an active investigation, complaint, recall, regulatory commitment, litigation or other hold should not be destroyed simply because their routine retention date has passed.

A Record Destruction Process May Include

  • Identification of records eligible for destruction
  • Verification that the retention period has expired
  • Confirmation that no hold applies
  • Authorization by designated personnel
  • Secure destruction method
  • Record of destruction

Confidential paper records may require secure shredding, while electronic records require controlled deletion or disposition procedures appropriate to the system.

Record Retention Problems and CAPA

Significant failures in record retention may require investigation and Corrective and Preventive Action (CAPA) .

Examples include repeated missing records, loss of electronic data, unreadable archives, uncontrolled destruction, incomplete migrations or recurring inability to retrieve required GMP information.

CAPA should address the underlying system weakness rather than only replacing the individual missing record where possible.

Common Record Retention Errors in Pharmaceuticals

No Retention Schedule Departments retain documents inconsistently because no approved retention matrix exists.
Records Destroyed Too Early Documents are disposed of before the required period expires.
Unreadable Archived Records Paper or electronic information deteriorates and can no longer be interpreted.
Missing Raw Data Summary reports are retained while important supporting data are lost.
Uncontrolled Archive Access Unauthorized personnel can remove or alter archived records.
Poor Indexing Records exist but cannot be located within a reasonable time.
Electronic Format Obsolescence Historical files cannot be opened after software or hardware is replaced.
Backup Used as Archive Disaster-recovery copies are assumed to satisfy long-term record retention without a retrieval strategy.
Missing Metadata Electronic records lose information needed to understand context, authorship or chronology.
No Destruction Authorization Records are discarded without documented approval.

Pharmaceutical Record Retention Audit Checklist

✓ Retention SOP: Is there an approved procedure for record retention and archival?
✓ Retention Matrix: Is every major record category assigned an approved retention period?
✓ Regulatory Basis: Are retention periods supported by applicable requirements?
✓ Record Ownership: Is responsibility for each record category defined?
✓ Storage: Are paper and electronic records appropriately protected?
✓ Access: Is archive access restricted?
✓ Indexing: Can required records be located efficiently?
✓ Legibility: Do retained records remain readable?
✓ Completeness: Are supporting and raw data retained where required?
✓ Electronic Records: Are metadata, audit trails and relevant context preserved?
✓ Backup: Is there an appropriate recovery strategy for electronic records?
✓ Migration: Is long-term accessibility considered when systems change?
✓ Retrieval: Can archived records be produced when requested?
✓ Destruction: Is record destruction documented and authorized?
✓ Record Holds: Are records protected from destruction when an investigation or other hold applies?
✓ ALCOA+: Does the retention system preserve data integrity throughout the record lifecycle?

Key Takeaway

Pharmaceutical record retention is not simply long-term storage. Records must remain complete, protected, readable, retrievable and meaningful throughout their approved retention period. A robust system combines a documented retention schedule, secure paper and electronic archives, ALCOA+ data-integrity controls, reliable retrieval, controlled destruction and appropriate management of historical data when systems or technologies change.

Frequently Asked Questions About Pharmaceutical Record Retention

1. What is record retention in pharmaceuticals?

Record retention is the controlled preservation of pharmaceutical records for a defined period so that they remain readable, protected and retrievable when required.

2. Why is record retention important in GMP?

Retained records provide evidence of manufacturing, testing and quality activities and may be needed during audits, complaints, investigations, recalls or regulatory inspections.

3. How long should pharmaceutical records be retained?

There is no single retention period applicable to all pharmaceutical records. The period depends on the record type, product, applicable regulatory framework, market requirements and company retention policy.

4. What is a record retention schedule?

A retention schedule is a controlled list that identifies record categories, responsible departments, retention periods, storage locations and disposition requirements.

5. Which pharmaceutical records should be retained?

Examples include batch records, laboratory data, stability records, training records, validation documents, calibration records, deviations, CAPA, change controls, complaints, logbooks and distribution records.

6. Can pharmaceutical records be stored electronically?

Yes. Electronic records may be retained in appropriately controlled systems that preserve accessibility, security, integrity, traceability and long-term readability.

7. What is the difference between backup and archival?

Backup primarily supports recovery after data loss or system failure, while archival supports long-term preservation and retrieval of required records.

8. How does ALCOA+ apply to record retention?

Retention controls should preserve record attribution, legibility, chronology, originality, accuracy, completeness, consistency, endurance and availability throughout the record lifecycle.

9. When can pharmaceutical records be destroyed?

Records should only be destroyed after the applicable retention period has expired, required authorization has been obtained and no investigation, legal hold or other reason requires continued retention.

10. What is an archive retrieval log?

An archive retrieval log records the removal and return of archived records and may identify the requester, record reference, dates and storage location.

11. What should happen when an electronic system becomes obsolete?

Required regulated records should remain accessible and meaningful, which may require controlled migration, preservation of the legacy system or another validated long-term retrieval strategy.

12. Why should raw data be retained?

Raw and supporting data may be necessary to reconstruct the original activity, verify reported results and support investigations or regulatory review.

Educational note: Pharmaceutical record-retention periods differ by jurisdiction, product type, record category and regulatory framework. Do not use a generic number of years for every record. Companies should establish an approved retention matrix based on current applicable regulations, product requirements and their Pharmaceutical Quality System.